Market Cap 10.38M
Revenue (ttm) 3.22M
Net Income (ttm) -4.55M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -141.30%
Debt to Equity Ratio 0.00
Volume 6,100
Avg Vol 33,786
Day's Range N/A - N/A
Shares Out 5.85M
Stochastic %K 54%
Beta 0.82
Analysts Strong Sell
Price Target $5.00

Company Profile

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune su...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3 Carlton South, Carlton, Australia
Baazigar30
Baazigar30 Jul. 7 at 10:05 PM
$IMRN Float & OS: 3.82M/ 5.84 My target $10 Do your own DD imo
0 · Reply
Baseball89
Baseball89 Jun. 30 at 8:14 PM
$NCNA $IMRN what is going on with this stock? Its spiked today. Any news? Is this one waking up?
0 · Reply
Baseball89
Baseball89 Jun. 26 at 6:43 PM
$CYN $IMRN ---very good technicals Let's get this one moving. Hot!
0 · Reply
twisrs
twisrs Jun. 26 at 6:33 PM
$BIAF $ASTI $CYN $VOR i like $IMRN needs volume I'm buying here
0 · Reply
Baseball89
Baseball89 Jun. 26 at 6:00 PM
$MKDW $IMRN has low float. Let's get this thing moving. Solid. Double corporate earnings, military 🪖 contracts,revenue growth
0 · Reply
Baseball89
Baseball89 Jun. 26 at 5:51 PM
$CYN $IMRN ---low float hello.. you seeing this.
0 · Reply
Baseball89
Baseball89 Jun. 26 at 5:32 PM
$CYN I'm banking on $IMRN . Getting in early on this one.
1 · Reply
Baseball89
Baseball89 Jun. 26 at 5:25 PM
$CYN $IMRN could be the next one.
0 · Reply
Baseball89
Baseball89 Jun. 26 at 1:04 PM
$BDRX $IMRN ..... This one looks solid. Continue quarterly revenue growth. This one needs some traction. Shares are cheap. US military contract... Travelan
1 · Reply
Baseball89
Baseball89 Jun. 26 at 10:58 AM
$NCNA $IMRN ---this one looks solid. Keep on your radar. Continued revenue growth per quarter.
0 · Reply
Latest News on IMRN
Immuron Letter to Shareholders: Projects Update

May 30, 2025, 6:00 AM EDT - 5 weeks ago

Immuron Letter to Shareholders: Projects Update


Immuron Travelan® highest sales in history

Apr 10, 2025, 6:00 PM EDT - 3 months ago

Immuron Travelan® highest sales in history


Immuron Travelan® continued strong sales growth

Jan 17, 2025, 6:00 AM EST - 6 months ago

Immuron Travelan® continued strong sales growth


Immuron Announces Travelan® Clinical Trial Update

Jan 14, 2025, 6:00 AM EST - 6 months ago

Immuron Announces Travelan® Clinical Trial Update


Immuron Plans Phase 2 Trial for IMM-529 following FDA review

Sep 5, 2024, 11:54 AM EDT - 10 months ago

Immuron Plans Phase 2 Trial for IMM-529 following FDA review


Immuron requests pre-IND meeting for IMM-529 with FDA filing

Jul 2, 2024, 6:00 AM EDT - 1 year ago

Immuron requests pre-IND meeting for IMM-529 with FDA filing


Immuron Board Changes

May 31, 2024, 6:00 AM EDT - 1 year ago

Immuron Board Changes


Immuron CEO Steven Lydeamore to present at Peak Sky High

May 31, 2024, 6:00 AM EDT - 1 year ago

Immuron CEO Steven Lydeamore to present at Peak Sky High


Immuron Limited to Present at the Emerging Growth Conference

May 7, 2024, 6:00 AM EDT - 1 year ago

Immuron Limited to Present at the Emerging Growth Conference


Immuron Director Resignation

May 3, 2024, 6:00 AM EDT - 1 year ago

Immuron Director Resignation


Immuron to host Live Virtual Event

Apr 15, 2024, 6:00 AM EDT - 1 year ago

Immuron to host Live Virtual Event


Immuron Travelan® sales continued strong growth

Apr 10, 2024, 6:00 AM EDT - 1 year ago

Immuron Travelan® sales continued strong growth


Immuron Presentation Australian Biologics Festival 2024

Feb 21, 2024, 6:00 AM EST - 1 year ago

Immuron Presentation Australian Biologics Festival 2024


Immuron achieves record Travelan® sales

Feb 13, 2024, 6:00 AM EST - 1 year ago

Immuron achieves record Travelan® sales


Immuron CEO, Steven Lydeamore Investor Webinar Presentation

Feb 8, 2024, 6:00 AM EST - 1 year ago

Immuron CEO, Steven Lydeamore Investor Webinar Presentation


Immuron achieves record half yearly Travelan® sales

Jan 16, 2024, 6:00 AM EST - 1 year ago

Immuron achieves record half yearly Travelan® sales


Immuron Clinical Trials Update

Dec 22, 2023, 6:00 AM EST - 1 year ago

Immuron Clinical Trials Update


Immuron CEO Steven Lydeamore Investor Webinar Presentation

Nov 13, 2023, 6:00 PM EST - 1 year ago

Immuron CEO Steven Lydeamore Investor Webinar Presentation


Immuron CEO Steven Lydeamore presented at AusBioInvest

Oct 30, 2023, 7:21 AM EDT - 1 year ago

Immuron CEO Steven Lydeamore presented at AusBioInvest


Immuron achieves record quarterly Travelan® sales

Oct 11, 2023, 6:00 AM EDT - 1 year ago

Immuron achieves record quarterly Travelan® sales


Immuron achieves record monthly Travelan® sales

Sep 13, 2023, 6:00 AM EDT - 1 year ago

Immuron achieves record monthly Travelan® sales


Immuron CEO, Steven Lydeamore to present at H.C. Wainwright

Sep 11, 2023, 6:00 AM EDT - 1 year ago

Immuron CEO, Steven Lydeamore to present at H.C. Wainwright


Immuron CEO, Steven Lydeamore to present at Bioshares

Jul 24, 2023, 6:00 AM EDT - 2 years ago

Immuron CEO, Steven Lydeamore to present at Bioshares


Immuron FY23 Sales increase 136% on FY22 Sales

Jul 5, 2023, 6:00 AM EDT - 2 years ago

Immuron FY23 Sales increase 136% on FY22 Sales


Immuron Chairman Transition

Jun 30, 2023, 6:00 AM EDT - 2 years ago

Immuron Chairman Transition


Immuron Business Update: Letter to Shareholders

Jun 22, 2023, 6:00 AM EDT - 2 years ago

Immuron Business Update: Letter to Shareholders


Immuron Initiates Recruitment of Travelan® Clinical Study

May 30, 2023, 6:00 AM EDT - 2 years ago

Immuron Initiates Recruitment of Travelan® Clinical Study


Immuron CEO, Steven Lydeamore to present at Coffee Microcaps

May 2, 2023, 6:00 AM EDT - 2 years ago

Immuron CEO, Steven Lydeamore to present at Coffee Microcaps


Baazigar30
Baazigar30 Jul. 7 at 10:05 PM
$IMRN Float & OS: 3.82M/ 5.84 My target $10 Do your own DD imo
0 · Reply
Baseball89
Baseball89 Jun. 30 at 8:14 PM
$NCNA $IMRN what is going on with this stock? Its spiked today. Any news? Is this one waking up?
0 · Reply
Baseball89
Baseball89 Jun. 26 at 6:43 PM
$CYN $IMRN ---very good technicals Let's get this one moving. Hot!
0 · Reply
twisrs
twisrs Jun. 26 at 6:33 PM
$BIAF $ASTI $CYN $VOR i like $IMRN needs volume I'm buying here
0 · Reply
Baseball89
Baseball89 Jun. 26 at 6:00 PM
$MKDW $IMRN has low float. Let's get this thing moving. Solid. Double corporate earnings, military 🪖 contracts,revenue growth
0 · Reply
Baseball89
Baseball89 Jun. 26 at 5:51 PM
$CYN $IMRN ---low float hello.. you seeing this.
0 · Reply
Baseball89
Baseball89 Jun. 26 at 5:32 PM
$CYN I'm banking on $IMRN . Getting in early on this one.
1 · Reply
Baseball89
Baseball89 Jun. 26 at 5:25 PM
$CYN $IMRN could be the next one.
0 · Reply
Baseball89
Baseball89 Jun. 26 at 1:04 PM
$BDRX $IMRN ..... This one looks solid. Continue quarterly revenue growth. This one needs some traction. Shares are cheap. US military contract... Travelan
1 · Reply
Baseball89
Baseball89 Jun. 26 at 10:58 AM
$NCNA $IMRN ---this one looks solid. Keep on your radar. Continued revenue growth per quarter.
0 · Reply
Baseball89
Baseball89 Jun. 26 at 10:48 AM
$IMRN who is quietly loading here? Low float. Look solid
0 · Reply
DipRipper33
DipRipper33 Jun. 24 at 3:37 PM
0 · Reply
NextBigRun
NextBigRun Jun. 20 at 2:39 AM
GLMD is sitting on a launchpad. Under cash, no debt, real GLP-1/fibrosis catalysts, and a float that already sent it to $2.08 without news. The setup is rare and it’s ready. $SHPH $TRVN $IMRN $TIVC
0 · Reply
YasirTrades
YasirTrades Jun. 20 at 2:27 AM
GLMD is the sleeper play of the year. Trading below cash, zero debt, real biotech catalysts ahead, and a float that already pushed it to $2.08. When eyes return, this could ignite fast. $PHGE $IMRN $VTAK $PRSO
0 · Reply
YasirTrades
YasirTrades Jun. 18 at 2:16 PM
GLMD is a ticking time bomb 💣 Trading under cash. $20+ book. No debt. Tiny float. GLP-1 catalyst loading. Chart is coiled tight. When volume hits… boom 💥 100%+ upside? That might be conservative. $TRVI, $LUNR, $IMRN, $RNXT ..
0 · Reply
GreenResearchers
GreenResearchers Jun. 16 at 9:52 AM
GLMD is a powder keg ready to blow. Trading under cash with a $20+ book value, no debt, and a tiny float this isn’t just undervalued, it’s insanely mispriced. The chart is tightening, momentum is building, and massive GLP-1 obesity + fibrosis catalysts are around the corner. This sector has sent names flying 500%+… GLMD hasn’t even started. When the spark hits volume, PR, or smart money rotation this could rip like wildfire. One of the cleanest high-upside setups on the entire market right now. $ATNF, $OPGN, $ACXP, $IMRN 🌙
0 · Reply
Baseball89
Baseball89 Jun. 10 at 10:11 AM
$LAES $BURU $IMRN --a sleeper $GPUS $FAAS Way undervalued
0 · Reply
Baseball89
Baseball89 Jun. 10 at 9:36 AM
$MLGO $IMRN ---this is asleeper about to wake up
0 · Reply
twisrs
twisrs Jun. 2 at 2:24 PM
$IMRN $2 soon!
0 · Reply
Baseball89
Baseball89 Jun. 2 at 11:34 AM
0 · Reply
Baseball89
Baseball89 Jun. 2 at 9:57 AM
$BMGL $IMRN ---no reverse splits, increased corporate earnings. Looks solid. Keep on watch.
0 · Reply
delvanbeyond
delvanbeyond Jun. 1 at 1:08 PM
$IMRN 📈📈📈
0 · Reply